OBDCMarch 30, 2026 at 8:00 PM UTCFinancial Services

OBDC's Hold Thesis Challenged by Deepening Credit Risks

Read source article

What happened

A Zacks article published on March 30, 2026, advocates holding Blue Owl Capital stock, citing its below-industry valuation and efforts to offset debt pressures with income growth and strategic deals. However, this optimistic view overlooks significant vulnerabilities detailed in the latest DeepValue master report and SEC filings. Non-accruals have risen from 0.7% to 1.3% of fair value in 2025, indicating credit deterioration in a late-cycle private-credit environment. Adjusted net investment income fell to $0.36 per share in Q3 2025, barely covering the $0.37 quarterly dividend and highlighting tightening earnings support. Moreover, governance risks from the failed OBDC II merger and clustered insider buying in November 2025 suggest underlying tensions that the article ignores, painting an incomplete picture of the investment case.

Implication

The stock's 15% discount to NAV offers potential upside, but this is contingent on stabilizing non-accruals and improving dividend coverage, which are currently deteriorating. Investors must closely monitor quarterly results for any further increase in non-accruals above 2% of fair value, a key risk flagged in the report. A dividend cut, likely if adjusted NII remains below $0.35 per share, could trigger a re-rating downward and erase the yield advantage. Utilization of the $200 million buyback authorization might provide temporary support, but it must be balanced against the need for capital preservation amid rising leverage. Given persistent governance overhangs and sector-wide private-credit fears, maintaining a cautious stance is prudent until clearer evidence of fundamental stability emerges over the next 6-12 months.

Thesis delta

The Zacks article presents a hold thesis based on valuation and income growth, but it does not shift the investment thesis from the DeepValue report's 'WAIT' rating. The report's concerns about rising non-accruals, tight dividend coverage, and governance risks remain unaddressed, reinforcing the need for patience rather than immediate investment. No new data in the article alters the fundamental outlook, so the thesis delta is minimal, with the analytical edge still favoring caution.

Confidence

medium